Medwise Certificate logo
Coming Soon!

Program Overview

MedWise Advisor certification provides clinicians in various care settings with clinical and operational training for medication risk mitigation services.

This MedWise Advisor certification is intended for pharmacists who are interested in improving medication safety and providing enhanced clinical services through the use of MedWise Science medication decision support tools.

Deliver concierge pharmacy services to your patients with cutting-edge medication safety technology

Transform your practice

Medwise® Science, proprietary medication safety technology, helps pharmacists identify and mitigate preventable medication-related problems. The MedWise Risk Score™ is available to certified MedWise Advisor pharmacists, along with an array of support tools, to launch your concierge pharmacist practice.

Participate in the MedWise Advisor Certificate Program to receive clinical and operational training for providing medication risk mitigation services in various care settings.

Training consists of self-paced ACPE accredited courses, along with operational training and demonstrations.

Benefits for completing this program include:

  • A deeper clinical understanding of drug burden
  • Further knowledge of multi-drug interactions
  • The ability to recommend more appropriate medication regimens
  • In-depth training on WedWise Science, including how to use the multi-drug interaction tools and SNOWMED functionality

How It Works

This program is conducted in Four Parts:

  1. Self-study: Documenting a Patient Case
    • After completing operational platform training, learners will be given three standardized cases to complete and return documentation. Learners will be evaluated by TRHCU pharmacists and given feedback on their work.
  2. Eight-hour Clinical Case Discussion 
    • Clinical application of aggregated anticholinergic burden and aggregated sedative burden; aggregated Long QT Syndrome; competitive inhibition burden; drug interactions with inhibitors and inducers.
    • Optimizing patient outcomes through effective documentation: Aggregated anticholinergic burden and aggregated sedative burden; Aggregated Long QT Syndrome; Competitive inhibition burden; Inhibitors and inducers.
  3. MedWise Advisor Certification Final Exam
  4. Self-study: Final Medication Risk Mitigation Assessment

Continuing Education

This learning plan includes a combination of self-paced learning and live case discussion. Learners will earn 16 hours of continuing education for sucessfully completing the course components.

Credits will be reported to the National Association of Boards of Pharmacy (NABP) within 30 days of successful completion of each clinical module that offers continuing education credits if TRHCU has been provided with all learner information required by the NABP. This includes NABP ID and birthdate (MMDD).

Upon watching the videos and completing the post-tests with at least 80 percent correct answers, you will be able to download a PDF certificate for your records. Credit is also available upon completion of the Pharmacist-driven Medication Risk Mitigation Certificate Program.

 

Refer to the Program Brochure for detailed information on the specific continuing education credits. 

Accreditation

In support of improving patient care, TRHC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Disclosure of Conflicts of Interest: TRHC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to TRHC policy. TRHC is committed to providing its learners with high-quality continuing medical education (CME) activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

 

Refer to Program Brochure for full list of disclosures

joint accredit

Course Information

Desired Outcomes

After completing this program, learners should demonstrate the ability to:

  • Make clinical recommendations based on the proprietary MedWise® Matrix
  • Identify medication-related problems and plan recommendations
  • Realize the increased significance of patient consulting
  • Review Systemized Nomenclature of Medicine (SNOMED) functionality

Benefits to Participants

  • Deeper clinical understanding of drug burden
  • Further knowledge of multi-drug interactions and risk mitigation
  • Ability to make more appropriate recommendations to optimize patient outcomes

Course Faculty

  • Jessica DiLeo, PharmD, BCGP, BCACP, CMWA -[Disclosure-Employee of Tabula Rasa HealthCare Inc]